ERBB2 and gastric cancer: Moreover, up-regulation of MMP-2 and MMP-9, and also activation of the nuclear factor (NF)-κB anti-apoptotic pathway may arise from HER2 overexpression, as shown strongly in breast and gastric cancers [106, 107].